Results
Breast milk concentrations of PG E were 149 ± 37 pg/ml (mean ± SEM) in foremilk and 224 ± 63 in hindmilk. Eight out of 10 paired samples showed a rise in concentration from foremilk to hindmilk (P <0*02). These levels were very significantly higher than plasma concentrations of PG E of 1 *3 ± 0 1 in healthy adults (P<0 001) (Fig. 1 hindmilk 425 ± 152 and 671 ± 322 pg/ml respectively and were greatly raised above the adult plasma level of 3*6 ± 02 (P<0*001) (Fig. 1) . PGFM concentrations were 192 ± 71 in foremilk and 214 ± 86 in hindmilk, compared with 57 ± 4 in adult plasma (P<0 01) (Table) . Thus, the mean PGFM/ PG F ratios were 0 *5 for foremilk and 0 * 3 for hindmilk, both substantially lower than the mean ratio in adult plasma of 15 8 (Fig. 2) . Foremilk concentrations of TXB2 and 6-keto-PG F1a are shown in the It is thought that prostaglandins play a role in gastrointestinal motility. Both exogenous PG F, given to induce therapeutic abortion, and endogenous overproduction of PG E and PG F have been described in association with diarrhoea.6-7 We have considered that ingested prostaglandins could also modulate gut motility. Pickles et al.8 thought that infantile diarrhoea might be due occasionally to excessive prostaglandin secretion into milk during menstruation, when maternal plasma levels of PG F may be raised, but it is possible that in the healthy breast-fed infant prostaglandins could assist peristalsis physiologically.
It is possible that differences in the pattern of bowel evacuation in breast-fed and bottle-fed infants could relate to differences in ingested prostaglandins. However, we have not studied prostaglandins in formula feeds, but PG F has been demonstrated to be present in substantial amounts in untreated cows' milk.9
It is interesting that in the case of PG E and the metabolite of thromboxane A2, TXB2, the concentration rose towards the end of the feed. This cannot be explained entirely on the basis of the increasing milk fat content during a feed since the other prostaglandins measured did not behave in this way.
Two inactive metabolites, TXB2 and 6-keto-PG Fia, were found in human milk at levels similar to those seen in control plasma. The presence of these lipids implies that milk contains, or contained, the parent compounds thromboxane A2 and prostacyclin. Thromboxane A2 is a powerful vasoconstrictor and aggregates platelets whereas prostacyclin is a potent vasodilator and inhibits platelet aggregation. Since we were unable to measure these active forms directly, their survival in human milk is unknown and it is a matter for speculation if these biologically important lipids could exert a 'topical' effect on the gut, or perhaps be absorbed sufficiently to have systemic effects on the infant.
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